Removal of Beta Blocker Drugs by Hemodialysis
NCT03361280
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Diseases
Interventions
DRUG:
Beta blocker
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's